This series on “Lung Transplantation: New Frontiers”, edited by Dr. Haytham Elgharably from Cleveland Clinic, explores the latest advancements in lung transplantation, focusing on cutting-edge technologies, innovative surgical methods, and updates in donor management and allocation systems. It will provide unique and practical insights into how these developments can optimize outcomes and transform lung transplantation.
Haytham Elgharably, MD
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA
Dr. Elgharably is a board certified Cardiac Surgeon with special interest in lung transplant research, including ischemia-reperfusion injury and clinical outcomes. His specialties include lung transplantation, pulmonary endarterectomy, and different aspects of complex adult cardiac surgery. Currently, he is the surgical director of the Endocarditis Center at the Cleveland Clinic and co-director of quality at the department of Thoracic & Cardiovascular Surgery. He holds a parrellel appointment as Assistant Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.
Series outline:
- Trans-catheter therapy in patients with advance lung disease undergoing lung transplantation
- Management of existing gastrointestinal pathology in patients undergoing lung transplantation
- Ex-vivo lung perfusion experimental platform and therapeutic potentials
- Extended donor criteria for lung transplantation
- Evolution of allocation system for lung transplantation
- Lung transplantation in the era normothermic regional perfusion in donation after cardiac death
- Evolving experience with portable ex-vivo lung perfusion in lung transplantation
- Emerging roles for ex-vivo lung perfusion (EVLP) in lung transplantation
Disclosure:
The series “Lung Transplantation: New Frontiers” was commissioned by the editorial office, Current Challenges in Thoracic Surgery without any sponsorship or funding. Haytham Elgharably serves as the unpaid Guest Editor for the series.